Health Care & Life Sciences » Pharmaceuticals | Otsuka Holdings Co. Ltd.

Otsuka Holdings Co. Ltd.

Otsuka Holdings Co. Ltd. ADR
Stock Exchange Other OTC
EPS
$0.65
Market Cap
$19.34 B
Shares Outstanding
1.12 B
Public Float
-
Otsuka Holdings Co. Ltd.
Stock Exchange Other OTC
EPS
$1.29
Market Cap
$19.64 B
Shares Outstanding
-
Public Float
-
Otsuka Holdings Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY142.41
Market Cap
JPY2.1 T
Shares Outstanding
557.84 M
Public Float
388.56 M

Profile

Address
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
Employees -
Website http://www.otsuka.com
Updated 07/08/2019
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases.

Financials

View All
Created with Highcharts 5.0.14Otsuka Holdings Co. Ltd.Net Income. Fiscal year is January-December. All values JPY Millions.150 989150 989101 957101 95792 56392 563112 492112 49282 49282 49220142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Otsuka Holdings Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values JPY Millions.1 452 7591 452 7591 427 3751 427 3751 195 7461 195 7461 239 9521 239 9521 291 9811 291 981201420152016201720180250k500k750k1 000k1 250k1 500k1 750k

Ichiro Otsuka
Chairman
Tatsuo Higuchi
President, CEO & Representative Director